Hence, we speculate that the METTL3/miR-146a-5p/SMAD4 axis could serve to facilitate this switch in OSCC, thereby converting the tumor-suppressive properties of TGF-β signaling into tumor-promotive capabilities. The gene discussed is SMAD4; the disease is neoplasm.